Neurogene
Stuart Cobb is a distinguished scientist with extensive experience in the field of neuroscience. Currently serving as Chief Scientific Officer at Neurogene Inc. since January 2019, Stuart also holds the position of Principal Investigator at The University of Edinburgh since November 2017. Prior to these roles, Stuart led a research lab and was the head of the Centre for Neuroscience at The University of Glasgow from October 1999 to October 2017 and worked as a postdoctoral researcher at the University of Edinburgh from October 1996 to September 1999. Early in their career, Stuart contributed as a researcher at Inveresk Research from August 1987 to September 1989. Stuart earned a DPhil in Neuroscience from the University of Oxford between 1993 and 1996 and a first-class BSc in Pharmacology from the University of Glasgow from 1989 to 1993.
This person is not in any offices
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.